Overview
Tab Title Description
Study IDs
Site IRB
- Rochester, Minnesota: 20-002775
About this study
The purpose of this research is to evaluate multiple new tests for detection of antibodies to SARS-CoV-2, the cause of COVID19, in blood samples.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Over the age of 18 and under the age of 60 who have been recently tested clinically for COVID-19.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Elitza Theel, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available